Richard J Pleass

5PUBLICATIONS
5CO-AUTHORS
Cancer geneticsGlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 16, 2025
Genetic Divergence and Antibody Expression Influence the N-Glycomes of CHO-K1 and CHO-S Cells.

Roberto Donini, Pat Blundell, Richard J Pleass

|Jul 21, 2021
The therapeutic potential of sialylated Fc domains of human IgG.

Richard J Pleass

|Apr 21, 2021
Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.

Christine Baksmeier, Pat Blundell, Julia Steckel

|Jan 08, 2020
Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses.

Patricia A Blundell, Dongli Lu, Anne Dell

|Jan 27, 2019
Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus.

Patricia A Blundell, Dongli Lu, Mark Wilkinson

Pageof 1

Frequent Collaborators

3 joint publications

Stuart M Haslam

2 joint publications

Patricia A Blundell

1 joint publications

Roberto Donini

1 joint publications

Anne Dell